Rainmed Medical Limited (HKG:2297)
Hong Kong · Delayed Price · Currency is HKD 0.1620
+0.0020 (1.25%)
Oct 8, 2026, 10:32 AM HKT
Rainmed Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 23.44 | 19.18 | 39.82 | 73.22 | 83.6 | 81.2 | |
Revenue Growth | 0.35% | -51.85% | -45.61% | -12.42% | 2.96% | - |
Cost of Revenue | 10.24 | 10.14 | 15.96 | 24.67 | 13.78 | 12.17 |
Gross Profit | 13.2 | 9.04 | 23.87 | 48.55 | 69.82 | 69.03 |
Selling, General & Admin | 63.51 | 71.12 | 97.84 | 145.57 | 176.07 | 185.33 |
Research & Development | 12.33 | 13.77 | 35.44 | 41.33 | 44.17 | 26.97 |
Other Operating Expenses | -0.5 | -0.99 | -9.29 | -6.69 | -5.23 | -0.43 |
Operating Expenses | 75.34 | 83.9 | 124 | 180.21 | 215.01 | 211.87 |
Operating Income | -62.14 | -74.86 | -100.13 | -131.66 | -145.19 | -142.84 |
Interest Expense | -0.8 | -0.72 | -0.94 | -1.31 | -0.76 | -3.86 |
Interest & Investment Income | 0.24 | 0.5 | 3.93 | 12.41 | 3.5 | 1.81 |
Currency Exchange Gain (Loss) | -0.36 | 0.24 | -0.66 | 1.08 | 2.02 | 0.07 |
Other Non Operating Income (Expenses) | - | - | - | - | -1,211 | -493.87 |
EBT Excluding Unusual Items | -63.06 | -74.84 | -97.79 | -119.48 | -1,351 | -638.68 |
Impairment of Goodwill | -6.81 | -6.81 | -5.78 | - | - | - |
Gain (Loss) on Sale of Investments | 1.8 | 2.48 | 1.25 | 2.4 | 0 | 0.04 |
Gain (Loss) on Sale of Assets | -0.08 | -0.27 | -0.01 | -0.01 | -0.02 | -0.04 |
Asset Writedown | -0 | - | -12.98 | - | - | - |
Pretax Income | -69.17 | -79.44 | -115.3 | -117.09 | -1,351 | -638.69 |
Income Tax Expense | -0.05 | -0.04 | 0.24 | -0.02 | -5.45 | -5.04 |
Earnings From Continuing Operations | -69.12 | -79.41 | -115.54 | -117.07 | -1,346 | -633.65 |
Minority Interest in Earnings | 2.22 | 2.32 | 2.05 | 1.24 | - | 0 |
Net Income | -66.9 | -77.08 | -113.5 | -115.83 | -1,346 | -633.65 |
Net Income to Common | -66.9 | -77.08 | -113.5 | -115.83 | -1,346 | -633.65 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1,348 | 1,292 | 1,168 | 1,168 | 898 | 643 |
Shares Outstanding (Diluted) | 1,348 | 1,292 | 1,168 | 1,168 | 898 | 643 |
Shares Change | 14.76% | 10.63% | - | 30.01% | 39.63% | - |
EPS (Basic) | -0.05 | -0.06 | -0.10 | -0.10 | -1.50 | -0.99 |
EPS (Diluted) | -0.05 | -0.06 | -0.10 | -0.10 | -1.50 | -0.99 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -211.41 | -81.49 | -128.5 | -208.97 | -128.33 | -103.67 |
Free Cash Flow Per Share | -0.16 | -0.06 | -0.11 | -0.18 | -0.14 | -0.16 |
Gross Margin | 56.31% | 47.14% | 59.93% | 66.31% | 83.52% | 85.02% |
Operating Margin | -265.06% | -390.38% | -251.43% | -179.81% | -173.66% | -175.91% |
Profit Margin | -285.39% | -401.98% | -284.99% | -158.20% | -1609.93% | -780.36% |
Free Cash Flow Margin | -901.80% | -424.94% | -322.68% | -285.40% | -153.50% | -127.67% |
EBITDA | -62.11 | -67.39 | -82.02 | -115.1 | -134.39 | -136.74 |
EBITDA Margin | -264.93% | - | -205.94% | -157.20% | -160.74% | -168.40% |
D&A For EBITDA | 0.03 | 7.47 | 18.11 | 16.56 | 10.8 | 6.1 |
EBIT | -62.14 | -74.86 | -100.13 | -131.66 | -145.19 | -142.84 |
EBIT Margin | -265.06% | - | -251.43% | -179.81% | -173.66% | -175.91% |